Xcout Intel
CellX competitors & alternatives
The 12 closest competitors and alternatives to CellX among food and biotechnology companies — ranked by similarity to what CellX actually does, not by market-cap band.
Subscribe to see CellX’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CellX
CellX Biosolutions AG is an ETH Zurich-born startup founded in 2024 and headquartered in Zurich, Switzerland. The company specializes in developing microbial technologies to sustainably treat chemical waste and pollutants such as PFAS and microplastics.
CellX at a glance
CellX is a food and biotechnology company headquartered in Switzerland. It has raised at least $15.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $11M in May 2022. Xcout tracks 2 named people at CellX, including Dr. Estelle Clerc (CEO).
CellX leadership
- Dr. Estelle ClercCEO
- Geoffrey BesnierCOO
CellX funding rounds
At least $15.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $11M | 2 named | |
| Seed | $4.3M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CellX competitors
Ranked by semantic similarity — how close each company is to CellX by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Biotechnology
StrainX Bioworks is a synthetic biology research company founded in 2023 that specializes in strain engineering, protein engineering, and precision fermentation to produce high-value alternatives.
Environmental Diagnostics
Biota Inc. is a Boulder, Colorado-based company founded in 2024 that helps testing labs boost revenue and supports companies working in PFAS remediation.
Biotechnology
ChemoSensoryX Biosciences SA is a biotechnology company that provides discovery products and services related to chemical communications mediated by human olfactory and taste receptors. Utilizing a proprietary technology platform and screening facilities, the company develops solutions for odor and taste management, including malodor blockers, pleasant odor enhancers, and applications for flavors, fragrances, and drug discovery.
Biotech
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Biotechnology
Cemvita Factory is a Houston-based industrial biotechnology company that engineers microorganisms and biological processes to decarbonize heavy industries, including energy and mining. Its solutions target applications such as biomanufacturing, biomining, and the production of lower-carbon fuels and chemicals for industrial customers.
Biotechnology
Cellvie AG is a biotechnology company based in Zurich, Switzerland, pioneering Therapeutic Mitochondria Transplantation to target cellular energy metabolism.
Biotech
Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic membrane mechanisms.
Biotechnology
Headquartered in Muttenz, Switzerland, Resistell AG is a biotechnology company incorporated in 2018 that develops rapid antibiotic susceptibility testing devices as an innovative alternative to traditional culture-based antibiograms.
Biotech
ATLyphe is a Swiss biotechnology spin-off from ETH Zurich and the University of Zurich founded in 2023 and based in Zürich. The company develops antibody-based solutions engaging T cells for precision immunotherapy, with a focus on improving hematopoietic stem cell transplantation conditioning methods.
Biotech
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entirely new molecular entities. Integral to its design, the SimplePath platform incorporates distinct modules, each housing one or more enzymes that work synergistically to facilitate specific biocatalytic transformations. The firm was established in 2014 and maintains its corporate headquarters in Monrovia, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CellX and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CellXand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →